自发性肾动脉夹层的腔内治疗结局
本研究回顾性分析了2007年1月至2018年8月间接受腔内治疗的14例自发性肾动脉夹层(SRAD)患者,平均年龄47岁,所有患者均伴高血压。腔内修复技术成功率为93.3%(14/15),无术后死亡,对高血压改善或治愈的有效率为85.7%,随访期间未见支架狭窄或闭塞。结论认为腔内修复安全、可行、有效,可作为开放血运重建的有前景的替代方案。
要点
- 腔内修复SRAD技术成功率93.3%,无术后死亡。
- 腔内修复对高血压改善或治愈的有效率为85.7%。
- 随访影像未见支架狭窄或闭塞。
核心结论
- 腔内修复是SRAD安全、可行、有效的治疗方法,应作为开放血运重建的有前景的替代方案。
研究设计与样本
- 回顾性综述,纳入2007年1月至2018年8月间接受腔内治疗的SRAD患者14例(12男2女),平均年龄47岁。
主要发现
- 所有患者均有高血压,新发占78.6%,既往存在占21.4%;突发胁腹痛为最常见症状。
- 14例患者共15条受累肾动脉,腔内修复成功实施于14条动脉,技术成功率为93.3%(14/15),无术后死亡。
- 腔内修复显著改善高血压和肾功能,且改善在随访期间持续;对高血压改善或治愈的有效率为85.7%。
- 随访影像显示接受腔内修复的患者无支架狭窄或闭塞征象。
临床怎么用
- 对于SRAD患者,腔内修复可作为开放血运重建的替代选择,尤其适用于高血压需改善或肾功能需保护者。
局限性
- 本研究为单中心回顾性综述,样本量小(14例患者,15条动脉),随访时间未明确报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess the outcomes of patients with spontaneous renal artery dissection (SRAD) after endovascular repair. METHODS: We performed a retrospective review of SRAD patients after endovascular treatment between January 2007 and August 2018. Demographic, clinical, ancillary testing, treatment, and outcome data were collected and analyzed. RESULTS: Fourteen patients (12 men and 2 women) with a mean age of 47 years were included in this study. All the patients had hypertension, either new onset (78.6%) or pre-existent (21.4%). Sudden flank pain was the most common symptom. Fourteen patients had 15 affected renal arteries. Endovascular repair was successfully performed in 14 arteries. The technical success rate of endovascular repair was 93.3% (14/15), with no postoperative death. Endovascular repair significantly improved hypertension and renal function, and these improvements persisted during the follow-up period. The effective rate of endovascular repair for improving or curing hypertension was 85.7%. Follow-up imaging showed no sign of stent stenosis or occlusion in those patients who received endovascular repair. CONCLUSIONS: Endovascular repair is safe, feasible, and effective for SRAD treatment and should be a promising alternative to open revascularization.
引用
- Jiang J, Li L, Liu Y, et al. Endovascular treatment of spontaneous renal artery dissection. J Vasc Surg. 2019. PMID: 31248763. doi:10.1016/j.jvs.2019.03.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。